# Childhood Acute Lymphoblastic Leukemia Treatment Protocol Moscow-Berlin 2008

> **NCT01953770** · NA · UNKNOWN · sponsor: **Federal Research Institute of Pediatric Hematology, Oncology and Immunology** · enrollment: 3000 (estimated)

## Conditions studied

- Childhood Acute Lymphoblastic Leukemia

## Interventions

- **DRUG:** PEG-L-asparaginase ind
- **DRUG:** PEG-L-asparaginase cons
- **DRUG:** E.coli L-asparaginase
- **DRUG:** High-dose Methotrexate
- **DRUG:** Low-dose Methotrexate
- **DRUG:** Triple intrathecal therapy
- **RADIATION:** Cranial irradiation
- **DRUG:** Daunorubicin

## Key facts

- **NCT ID:** NCT01953770
- **Lead sponsor:** Federal Research Institute of Pediatric Hematology, Oncology and Immunology
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-02
- **Primary completion:** 2015-01
- **Final completion:** 2020-07
- **Target enrollment:** 3000 (ESTIMATED)
- **Last updated:** 2020-02-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01953770

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01953770, "Childhood Acute Lymphoblastic Leukemia Treatment Protocol Moscow-Berlin 2008". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01953770. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*